Lazard Emerging Markets Equity Portfolio R6 Shares
Lazard Emerging Markets Equity Portfolio R6 Shares Fundamental Analysis
Lazard Emerging Markets Equity Portfolio R6 Shares (RLEMX) shows weak financial fundamentals with a PE ratio of 13.13, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze RLEMX's fundamental strength across five key dimensions:
Efficiency Score
WeakRLEMX struggles to generate sufficient returns from assets.
Valuation Score
ModerateRLEMX shows balanced valuation metrics.
Growth Score
ModerateRLEMX shows steady but slowing expansion.
Financial Health Score
WeakRLEMX carries high financial risk with limited liquidity.
Profitability Score
WeakRLEMX struggles to sustain strong margins.
Key Financial Metrics
Is RLEMX Expensive or Cheap?
P/E Ratio
RLEMX trades at 13.13 times earnings. This suggests potential undervaluation.
How Well Does RLEMX Make Money?
No data available.
Following the Money - Real Cash Generation
No data available.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
N/A
vs 25 benchmark
Current Ratio
Current assets to current liabilities
N/A
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
N/A
vs 25 benchmark
ROA
Return on assets percentage
N/A
vs 25 benchmark
ROCE
Return on capital employed
N/A
vs 25 benchmark
How RLEMX Stacks Against Its Sector Peers
| Metric | RLEMX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 24.15 | N/A |
| ROE | N/A | 15.00% | N/A |
| Net Margin | N/A | -30582.00% (disorted) | N/A |
| Debt/Equity | N/A | 0.77 | N/A |
| Current Ratio | N/A | 28.26 | N/A |
| ROA | N/A | 970.00% | N/A |
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Lazard Emerging Markets Equity Portfolio R6 Shares's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Blend, Diversified, Stable
EPS CAGR
N/A
Industry Style: Blend, Diversified, Stable
FCF CAGR
N/A
Industry Style: Blend, Diversified, Stable